glp-1 oral dosage for weight loss New GLP-1s are changing the game. In this Clinical Capsules episode, Vickie Danaher compares orforglipron and oral semaglutide on dosing, efficacy, and safety. Listen now what you need Oral Alternative to Ozempic May

Matsumoto, S., Ueda, T

Safety and efficacy in patients under 18 have not been established

Redox control of protein-DNA interactions: from molecular mechanisms to significance in signal transduction, gene expression, and DNA replication

A new study from the NYU Grossman School of Medicine, led by Lucas Mavromatis, suggests that #GLP1 receptor agonists - like #Ozempic #Semaglutide and #Zepbound #Tirzepatide - may do more than manage #diabetes and #weight: they could also help reduce the risk of 14 #obesity-related #cancers, especially in women

An educational video is available at ASCO and NCCN encourage feedback on their guidelines from oncologists, practitioners and patients through the ASCO Guidelines Wiki at www.asco.org/guidelineswiki or via the NCCN submission form at NCCN.org

Lynch is a naturopathic doctor (ND), he is not your treating physician, and will not have all the information he needs to give you accurate advice sometimes, a single issue will have underlying causes that can easily be overlooked via a simple, virtual comment or question